Senate Hearing Into Valeant Includes Top Hedge Fund Investor
Senate lawmakers investigating price hikes by the embattled drugmaker Valeant Pharmaceuticals will also question one of the company’s leading investors, hedge fund manager William Ackman. The Senate Aging More...
CEO of troubled pharmaceutical company Valeant admitted to hospital with ‘severe’ pneumonia
CEO Michael Pearson has been admitted for “severe” pneumonia, an emailed statement from Valeant spokeswoman Laurie Little says. J. Michael Pearson, 56, was admitted recently and is receiving More...
Reuters Exclusive: Valeant considers selling contact lens maker Paragon – sources
Valeant Pharmaceuticals is reaching out to potential buyers for its specialty contact lens manufacturing division, Paragon Vision Sciences, amid scrutiny from the Federal Trade Commission, according to More...
Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says
Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman Sachs to secure loans made to chairman and More...
Actavis Saves Allergan from Valeant Hostile Takeover with $66 Billion Deal, But Will Slash R&D
The seven-month battle over American Botox haven pharmaceutical company Allergan is over, after it accepted a friendly takeover bid from Irish integrated specialty pharmaceutical Actavis. The Actavis offer More...
Is Robert Goldfarb Backing Valeant Again To Catch Up To Big Pharma With Another Big Takeover ?
– – Big Pharma is in trouble these days as the cost of researching and qualifying new drugs has risen rapidly, and in inverse proportion it seems to their ability to find any. Increasingly, More...